HCA Healthcare, Inc. (HCA) is a publicly traded Healthcare sector company. As of September 11, 2026, HCA trades at $424.76 with a market cap of $91.19B and a P/E ratio of 22.24. HCA moved +1.36% today. Year to date, HCA is -9.24%; over the trailing twelve months it is +5.98%. Its 52-week range spans $295.00 to $556.52. Analyst consensus is buy with an average price target of $452.00. Rallies surfaces HCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for HCA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $424.76 |
| Market Cap | $91.19B |
| P/E Ratio | 22.24 |
| EPS | $19.25 |
| Dividend Yield | 0.78% |
| 52-Week High | $556.52 |
| 52-Week Low | $295.00 |
| Volume | 1.12M |
| Avg Volume | 0 |
| Revenue (TTM) | $64.97B |
| Net Income | $6.09B |
| Gross Margin | 0.00% |
20 analysts cover HCA: 0 strong buy, 12 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $452.00.